Evidence map›Paper›PMID 39304934›Full record

ArticleParasites & vectors2024

Leucinostatins from fungal extracts block malaria transmission to mosquitoes.

Guodong Niu, Xiaohong Wang, Wenda Gao, Liwang Cui, Jun Li

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guodong NiuDepartment of Biological Sciences, Florida International University, Miami, FL, 33199, USA.
Xiaohong WangDepartment of Biological Sciences, Florida International University, Miami, FL, 33199, USA.
Wenda GaoAntagen Pharmaceuticals, Canton, MA, 02021, USA.
Liwang CuiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.
Jun LiDepartment of Biological Sciences, Florida International University, Miami, FL, 33199, USA. lij@fiu.edu.

Funding

Fungal metabolites block malaria transmissionR01AI125657 · NIAID · FLORIDA INTERNATIONAL UNIVERSITY · PI LI, JUN · 2017 to 2021
$2.5M
National Institute of Allergy and Infectious Diseases R01AI125657NIAID NIH HHS R01 AI125657
6 · The paper itself

Abstract

backgroundMalaria is a mosquito-transmitted disease that kills more than half a million people annually. The lack of effective malaria vaccines and recently increasing malaria cases urge innovative approaches to prevent malaria. Previously, we reported that the extract from the soil-dwelling fungus Purpureocillium lilacinum, a common fungus from the soil, reduced Plasmodium falciparum oocysts in Anopheles gambiae midguts after mosquitoes contacted the treated surface before feeding.

methodsWe used liquid chromatography to fraction fungal crude extract and tract the active fraction using a contact-wise approach and standard membrane feeding assays. The purified small molecules were analyzed using precise mass spectrometry and tandem mass spectrometry.

resultsWe isolated four active small molecules from P. lilacinum and determined them as leucinostatin A, B, A2, and B2. Pre-exposure of mosquitoes via contact with very low-concentration leucinostatin A significantly reduced the number of oocysts. The half-maximal response or inhibition concentration (EC

conclusionsLeucinostatins, secondary metabolites from P. lilacinum disrupt malaria development, particular transmission to mosquitoes by contact. The contact-wise malaria control as a nonconventional approach is highly needed in malaria-endemic areas.

Indexed as

AnophelesPlasmodium falciparumAnimalsAntimalarialsAntimicrobial Cationic PeptidesChromatography, LiquidFemaleHypocrealesMalaria, FalciparumMosquito VectorsOocystsAntimalarialsAntimicrobial Cationic Peptidesleucinostatin AExternal sprayInfectionLeucinostatinMalariaMosquitoMultiple-stage antimalarialsTransmissionTransmission-blocking

Identifiers

PMID39304934
PMCPMC11414030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.